Hopp til innhold
NHI.no
Annonse

Ringorm: Smittefare

Innhold i artikkelen

Smittefaren opphører raskt ved behandling, og barn med ringorm kan gå i barnehage dagen etter igangsatt behandling. Ved utbrudd i brytermiljøer bør alle undersøkes, og matter bør rengjøres/desinfiseres.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Tinea corporis . Referanselisten for dette dokumentet vises nedenfor

  1. Yee G, Al Aboud AM. Tinea Corporis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 8, 2022. PMID: 31335080 PubMed
  2. Leung AKC, Lam JM, Leong KF, et al. Tinea corporis: an updated review. Drugs Context 2020; 9: 2020: 5-6. pmid:32742295 PubMed
  3. Martinez-Rossi NM, Peres NTA, Bitencourt TA, Martins MP, et al. State-of-the-Art Dermatophyte Infections: Epidemiology Aspects, Pathophysiology, and Resistance Mechanisms. J Fungi (Basel) 2021; 7(8): 629. pmid:34436168 PubMed
  4. Gupta AK, Foley KA, Versteeg SG. New Antifungal Agents and New Formulations Against Dermatophytes. Mycopathologia 2017; 182(1-2): 127-141. pmid:27502503 PubMed
  5. Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J 2016; 7(2): 77–86. pmid:27057486 PubMed
  6. Folkehelseinstituttet. Dermatofyttinfeksjoner (ringorm) – håndbok for helsepersonell. Smittevernhåndboka. Oslo: Folkehelseinstituttet; sist oppdatert 20.1.2024. Lest 19.2.2024. www.fhi.no
  7. Nordøy I, Gaustad P. Resistensproblemer ved behandling av invasive soppinfeksjoner. Tidsskr Nor Laegeforen 2008 ; 128(22): 2607-11. pmid:19023376 PubMed
  8. Nenoff P, Verma SB, Vasani R, et al. The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes-A molecular study. Mycoses 2019; 62(4): 336-356. pmid:30561859 PubMed
  9. Drakensjö IT, Chryssanthou E. Epidemiology of dermatophyte infections in Stockholm, Sweden: a retrospective study from 2005-2009. Med Mycol 2011; 49(5): 484-8. pmid:21128711 PubMed
  10. Švarcová M, Větrovský T, Kolařík M, et al. Defining the relationship between phylogeny, clinical manifestation, and phenotype for Trichophyton mentagrophytes/interdigitale complex; a literature review and taxonomic recommendations. Med Mycol 2023; 61(5): myad042. pmid:37070928 PubMed
  11. Thakur R, Kalsi AS. Outbreaks And Epidemics Of Superficial Dermatophytosis Due To Trichophyton mentagrophytes Complex And Microsporum canis: Global And Indian Scenario. Clin Cosmet Investig Dermatol 2019; 12: 887-893. pmid:31849509 PubMed
  12. Uhrlaß S, Verma SB, Gräser Y, at al. Trichophyton indotineae-An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India and Worldwide-A Multidimensional Perspective. J Fungi (Basel). 2022 Jul 21;8(7):757. PMID: 35887512. PubMed
  13. Moskaluk AE, VandeWoude S. Current Topics in Dermatophyte Classification and Clinical Diagnosis. Pathogens 2022; 11(9): 957. pmid:36145389 PubMed
  14. Centers for Disease Control and Prevention (CDC). Clinical Overview of Ringworm and Fungal Nail Infections. Atlanta: Centers for Disease Control and Prevention; 15.07.2024. Lest 19.02.2025 www.cdc.gov
  15. Zalewski A, Goldust M, Szepietowski JC. Tinea Gladiatorum: Epidemiology, Clinical Aspects, and Management. J Clin Med. 2022 Jul 14;11(14):4066. PMID: 35887830 PubMed
  16. Norsk forening for medisinsk mikrobiologi (NFMM). Hudavskrap. Metodebok.no. Oslo:NFMM; 22.04.2024, lest 19.02.2025 metodebok.no
  17. Folkehelseinstituttet. Strategimøte nr 27, 2013: Soppinfeksjoner. Oslo: Folkehelseinstituttet; desember 2015. www.fhi.no
  18. Durdu M, Ilkit M. Strategies to improve the diagnosis and clinical treatment of dermatophyte infections. Expert Rev Anti Infect Ther 2023; 21(1): 29-40. pmid:36329574 PubMed
  19. Levitt JO, Levitt BH, Akhavan A, Yanofsky H. The sensitivity and specificity of potassium hydroxide smear and fungal culture relative to clinical assessment in the evaluation of tinea pedis: a pooled analysis. Dermatol Res Pract 2010; 2010: 764843. pmid:20672004 PubMed
  20. Norsk forening for medisinsk mikrobiologi (NFMM). Dermatofytt DNA. Metodebok.no. Oslo: NFMM, sist oppdatert 13.02.2025. Siden besøkt 19.02.2025 metodebok.no
  21. Norsk forening for medisinsk mikrobiologi (NFMM). Dermatofyttdyrkning. Metodebok.no. Oslo: NFMM, sist oppdatert 13.02.2025. Siden besøkt 19.02.2025 metodebok.no
  22. El-Gohary M, van Zuuren EJ, Fedorowicz Z, et al. Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database Syst Rev. 2014 ;8:CD009992. DOI: 10.1002/14651858.CD009992.pub2. DOI
  23. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician 2008; 77: 1415-20. PubMed
  24. Norsk legemiddelhåndbok. L1.3.2.1 Imidazol-/triazolderivater (lokal bruk). Oslo: Foreningen for utgivelse av Norsk legemiddelhåndbok; sist oppdatert 21.06.2024. Siden besøkt 19.02.2025 www.legemiddelhandboka.no
  25. Norsk legemiddelhåndbok. L1.3.1.4 Terbinafin. Oslo: Foreningen for utgivelse av Norsk legemiddelhåndbok; sist oppdatert 21.06.2024. Siden besøkt 16.02.2025 www.legemiddelhandboka.no
  26. Relis: Terbinafin krem eller alternativ behandling av ringorm (tinea corporis) hos barn. RELIS database 2018; spm.nr. 10769, RELIS Sør-Øst. relis.no
  27. Verma S. Steroid modified tinea. BMJ 2017; 356: j973. pmid:28274995 PubMed
  28. Sharma P, Bhalla M, Thami GP, Chander J. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis. J Dermatolog Treat. 2020 Nov;31(7):749-753. Epub 2019 May 16. PMID: 31030594 PubMed
  29. Gupta AK, Talukder M, Carviel JL, Cooper EA, et al. Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis. J Eur Acad Dermatol Venereol 2023; 37(9): 1706-1717. pmid:37210652 PubMed
  30. Ebert A, Monod M, Salamin K, et al. Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multicentre study. Mycoses 2020; 63(7): 717-728. pmid:32301159 PubMed
  31. Ilkit M, Durdu M, Karakaş M. Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol 2012; 38(3): 191-202. pmid:22300403 PubMed
Annonse
Annonse